AcuTemp builds out a global cold-chain distribution network
Supplier of active and passive containers lines up regional providers in Asia, Middle East and South America
IMS Health weighs in with its analysis of drug shortages
Production volumes are actually up for some short-supply drugs, indicating a disconnect between manufacturers and the marketplace. Meanwhile, NCPD fights ‘price gouging’ claim
Drug Shortages Continue To Rise, With No Near-Term Resolution
A combination of regulatory processes and business practices are worsening an already-bad drug shortage situation
Life Cycle Management Without Borders
Taking a market-by-market approach to maximizing value after loss of exclusivity
A Roadmap to Optimizing Marketing Operations
Unifying a company’s approach to marketing fulfillment activities could provide innovation while delivering cost savings
Recalls Stimulate Scrutiny of Quality Assurance in Drug Packaging
With coupons, pharma is saying 'Let's make a deal' to consumers
Pharma marketers become adept at refining coupon and voucher programs, while technology options multiply. Meanwhile payer criticism mounts
Pharma IT is going to the clouds
Long used in clinical research, cloud computing is now entering commercial and business applications
IT Trends From the Trading Partner perspective
New HDMA 2011-2012 HDMA Factbook finds gradual growth in IT-based collaborations
A conversation with Steve Collis, AmerisourceBergen CEO
The Battle for Control of Specialty Drugs
Specialty distributors, specialty pharmacies and healthcare providers are all competing for a dominant position in drug delivery and reimbursement
ACOs and Their Impact on Pharma
Accountable care organizations will seek ‘economic and clinical value’ for pharmaceuticals
Fix the Drug Shortage Problem- Now
No major reaction to Obama drug-shortage executive order
Plan to address worsening drug-shortage sitaution has note spurred legislative activity
100% international air cargo screening is on hold, for now
Congressmen send a letter to TSA seeking an explanation for the delay
Where does the public go for flu info?
ComScore analysis finds CDC.gov highest-ranking site
AmerisourceBergen proposes a new approach to serialization
Tracking at the lot- rather than the item-level could address many security and tracking goals
Business-to-business publisher offers online contact to physicians that have diagnostics services
Online medical-diagnostics catalogues will have links to live pharma rep interations
Jazz Pharmaceutical's Xyrem drug has adverse-events, REMS problems
Company points finger at its specialty pharmacy for unreported deaths, but still gets hit with a Form 483
HDMA distributor sales are up 4.6%, to $274.5 billion through 2010
New edition of HDMA Factbook sees growth in generics, and the beginning of a slide in branded-drug revenues
Next chapter in drug shortages debate focuses on independent wholesalers
55% of drug-shortage causes are “unknown;” Congressional committee questions pricing, access and sources of short-supply drugs
'Changing commercial models' top list of pain points for pharma execs, says Cegedim survey
A higher focus on market access strategies, managed markets and salesforce realignments are the elements of addressing that pain
Biosimilar commercialization will be more like new branded drugs than generics, says Quintiles
Report focuses on the need for targeted clinical design, and commercialization strategies tailored to individual national markets
UPS Healthcare Logistics announces new cold chain option
Exclusive use of the PharmaPort 360 will allow more flexibility in shipping options, and enhanced tracking of a shipment
Contract Packagers, 3PLs Vie for Pharma 'Kitting' Services
When pharma deliveries involve a multicomponent kit, contractors offer dedicated services
2011 Product Security Report: Back to the Future
Industry is gearing up for another go at e-pedigree and anti-counterfeiting safeguards.
Drug shortages are opening the door to price gouging
Hospital pharmacies need to be vigilant in ensuring safe supplies of scarce drugs
Bloodied But Unbowed on the Personalized Medicine Battlefront
Do Dendreon’s troubles with over-optimistic sales forecasts put a cap on the promise of personalized medicine?
Book Review
Pharmaceutical Anti-Counterfeiting: Combating the Real Danger from Fake Drugs
Getting a Better Business Picture Through Gross-to-Net Analytics
Small changes in contract terms can have large consequences in net revenue
